Neoadjuvante Therapie von Tumoren des oberen Gastrointestinaltrakts
- 6 August 2010
- journal article
- Published by Springer Nature in Der Gastroenterologe
- Vol. 5 (5) , 412-422
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Incidence of Adenocarcinoma of the Esophagus Among White Americans by Sex, Stage, and AgeJNCI: Journal of the National Cancer Institute, 2008
- Chemoradiation Followed by Surgery Compared With Chemoradiation Alone in Squamous Cancer of the Esophagus: FFCD 9102Journal of Clinical Oncology, 2007
- Phase II Trial of Preoperative Chemoradiation in Patients With Localized Gastric Adenocarcinoma (RTOG 9904): Quality of Combined Modality Therapy and Pathologic ResponseJournal of Clinical Oncology, 2006
- Multicenter Phase II Trial of S-1 Plus Cisplatin in Patients With Untreated Advanced Gastric or Gastroesophageal Junction AdenocarcinomaJournal of Clinical Oncology, 2006
- Complete Response to Neoadjuvant Chemoradiotherapy in Esophageal Carcinoma Is Associated With Significantly Improved SurvivalJournal of Clinical Oncology, 2005
- Paclitaxel-Based Chemoradiotherapy in Localized Gastric Carcinoma: Degree of Pathologic Response and Not Clinical Parameters Dictated Patient OutcomeJournal of Clinical Oncology, 2005
- Multi-Institutional Trial of Preoperative Chemoradiotherapy in Patients With Potentially Resectable Gastric CarcinomaJournal of Clinical Oncology, 2004
- First demonstration of anti-lymphoma activity of BCL-2 antisense molecule-G3139; Results of phase I/IIA clinical trialEuropean Journal of Cancer, 1997
- Chemoradiotherapy Followed by Surgery Compared with Surgery Alone in Squamous-Cell Cancer of the EsophagusNew England Journal of Medicine, 1997
- Randomized Trial of Preoperative Chemotherapy for Squamous Cell Cancer of the EsophagusArchives of Surgery, 1992